Leuprorelin (Leuprolide) EP Impurity F serves as a reference peptide for identifying and quantifying related substances in leuprorelin preparations. Structural variation reveals how minor changes influence retention time, ionization, and folding. Researchers analyze it using LC-MS and orthogonal spectroscopic methods. Applications include impurity-specification work, process-characterization efforts, and synthetic-route refinement.
CAT No: Z10-101-196
CAS No:1872435-00-1
Synonyms/Alias:(S)-N-ethyl-1-(((S)-5-oxopyrrolidine-2-carbonyl)-D-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl)pyrrolidine-2-carboxamide;
Leuprorelin (Leuprolide) EP Impurity F is a specialized peptide impurity reference material commonly encountered during the synthesis and quality assessment of leuprorelin, a widely used gonadotropin-releasing hormone (GnRH) analog. Characterized by its unique peptide sequence distinct from the parent compound, this impurity serves as a critical analytical standard for laboratories engaged in pharmaceutical research, process optimization, and peptide characterization. With its well-defined structure, Leuprorelin EP Impurity F enables researchers to evaluate manufacturing consistency, monitor degradation pathways, and ensure the precise identification and quantification of related substances in leuprorelin-based preparations. Its availability supports robust analytical method development, helping to maintain high-quality standards throughout the drug development pipeline.
Analytical Method Development: Leuprorelin (Leuprolide) EP Impurity F is extensively utilized in the development and validation of chromatographic and spectrometric methods designed to detect and quantify impurities in peptide pharmaceuticals. Researchers incorporate this impurity as a reference standard to optimize separation conditions, determine detection limits, and validate the specificity and sensitivity of analytical assays. By providing a known impurity profile, it assists in distinguishing between structurally similar peptide fragments and the active pharmaceutical ingredient, ensuring that analytical methods are both accurate and reliable for routine quality control and batch release testing.
Process Optimization and Control: The presence of Leuprorelin EP Impurity F in synthetic peptide production processes offers valuable insights into reaction conditions and process parameters that may influence impurity formation. By monitoring the generation and levels of this impurity during various synthesis stages, process chemists can identify critical control points, adjust reaction conditions, and implement purification strategies to minimize its occurrence. This targeted approach not only enhances the overall yield and purity of leuprorelin but also streamlines manufacturing workflows, reducing costs and improving product consistency across production batches.
Degradation Pathway Elucidation: Studying Leuprorelin (Leuprolide) EP Impurity F aids in understanding the degradation mechanisms of leuprorelin under different storage and stress conditions. Researchers expose peptide formulations to heat, light, moisture, or oxidative environments and track the formation of this specific impurity to map out degradation pathways. This knowledge informs the design of more stable formulations and appropriate storage protocols, ultimately safeguarding the integrity of leuprorelin products throughout their shelf life and distribution.
Characterization of Reference Materials: The use of Leuprorelin EP Impurity F as a reference compound is essential for the structural elucidation and characterization of peptide standards. Advanced analytical techniques such as mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and high-performance liquid chromatography (HPLC) rely on well-characterized impurities to verify the identity and purity of reference materials. By comparing analytical profiles, researchers can confidently assign structural attributes, confirm sequence integrity, and ensure that reference standards used in research and development are of the highest quality.
Comparative Studies and Research Applications: Scientists often employ Leuprorelin (Leuprolide) EP Impurity F in comparative studies to evaluate the performance of new analytical instruments, reagents, or methodologies. Its defined chemical structure and consistent behavior make it an ideal candidate for benchmarking analytical technologies and assessing their suitability for peptide impurity analysis. In addition, it serves as a valuable tool for academic research focused on peptide chemistry, stability studies, and the development of next-generation peptide therapeutics. By enabling rigorous scientific investigation, Leuprorelin EP Impurity F contributes to the advancement of knowledge in peptide science and supports the continuous improvement of pharmaceutical quality assurance practices.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More